0001225208-24-005927.txt : 20240510 0001225208-24-005927.hdr.sgml : 20240510 20240510161659 ACCESSION NUMBER: 0001225208-24-005927 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240509 FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tsourapas Panagiotis CENTRAL INDEX KEY: 0001576945 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 24935136 MAIL ADDRESS: STREET 1: C/O COLGATE-PALMOLIVE COMPANY STREET 2: 300 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml X0508 4 2024-05-09 0000021665 COLGATE PALMOLIVE CO CL 0001576945 Tsourapas Panagiotis C/O COLGATE-PALMOLIVE COMPANY 300 PARK AVENUE NEW YORK NY 10022 1 Grp Pres, Eur& Developing Mkts 0 Common Stock 2024-05-09 4 M 0 12000.0000 72.2900 A 17118.0000 D Common Stock 2024-05-09 4 S 0 12000.0000 94.1545 D 5118.0000 D Common Stock 4345.0000 I By Issuer's 401(k) Plan Trustee Common Stock 69204.0000 I By Trust Stock Option (Right to Buy) 72.2900 2024-05-09 4 M 0 12000.0000 0.0000 D 2027-09-12 Common Stock 12000.0000 54794.0000 D Exercise of stock options awarded under the issuer's incentive compensation plan. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.15 to $94.1703, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. This amount includes 9,922 shares that were previously reported as directly beneficially owned. Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2019 grant date. /s/ Kristine Hutchinson, Attorney-in-Fact 2024-05-10